These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2882355)

  • 1. Influenza vaccination with adjuvant RU41740 in the elderly.
    Profeta ML; Guidi G; Meroni PL; Palmieri R; Palladino G; Cantone V; Zanussi C
    Lancet; 1987 Apr; 1(8539):973. PubMed ID: 2882355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 3. Influenza vaccine for 2018-2019.
    Med Lett Drugs Ther; 2018 Oct; 60(1558):169-173. PubMed ID: 30335044
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of influenza vaccination in the aged.
    Keren G; Segev S; Morag A; Zakay-Rones Z; Barzilai A; Rubinstein E
    J Med Virol; 1988 May; 25(1):85-9. PubMed ID: 3411310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for broadly protective influenza vaccines.
    Treanor JJ
    Vaccine; 2015 Nov; 33 Suppl 4():D39-45. PubMed ID: 26338145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccination in dialysis and transplant patients.
    Versluis DJ; Beyer WE; Masurel N; Weimar W
    Antiviral Res; 1985; Suppl 1():289-92. PubMed ID: 3909959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventive influenza vaccination].
    Glathe H
    Z Arztl Fortbild (Jena); 1990; 84(8):377-80. PubMed ID: 2378120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities for spring vaccination of schoolchildren against influenza].
    Zykov MP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):95-101. PubMed ID: 3904287
    [No Abstract]   [Full Text] [Related]  

  • 9. Influenza vaccine for 2017-2018.
    Med Lett Drugs Ther; 2017 Oct; 59(1531):163-166. PubMed ID: 28977806
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza vaccination with 1/10th the full dose.
    Cooper CL; Davis H; Cameron DW
    N Engl J Med; 2004 Nov; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.
    Chen D; Periwal SB; Larrivee K; Zuleger C; Erickson CA; Endres RL; Payne LG
    J Virol; 2001 Sep; 75(17):7956-65. PubMed ID: 11483740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza at Lowry Air Force Base in Denver, 1982-1986.
    Meiklejohn G; Zajac RA; Evans ME
    J Infect Dis; 1987 Oct; 156(4):649-51. PubMed ID: 3624907
    [No Abstract]   [Full Text] [Related]  

  • 13. Influenza vaccines.
    Brede HD
    Int Arch Allergy Immunol; 1995 Dec; 108(4):318-20. PubMed ID: 7580301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
    Vesikari T; Pellegrini M; Karvonen A; Groth N; Borkowski A; O'Hagan DT; Podda A
    Pediatr Infect Dis J; 2009 Jul; 28(7):563-71. PubMed ID: 19561422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
    Nunzi E; Iorio AM; Camilloni B
    Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.
    Van Hoecke C; Prikazsky V; Utö I; Menschikowski C
    Gerontology; 1996; 42(4):190-8. PubMed ID: 8832266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for poor immune response to influenza vaccination in elderly people.
    Bellei NC; Carraro E; Castelo A; Granato CF
    Braz J Infect Dis; 2006 Aug; 10(4):269-73. PubMed ID: 17293910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.
    El Sahly H
    Expert Rev Vaccines; 2010 Oct; 9(10):1135-41. PubMed ID: 20923265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.